Brucellosis Market research report– by species (Brucella suis, B. abortus, B. melitensis), Diagnosis (serological tests, molecular techniques, bone marrow biopsy, CT, MRI), Treatment (vaccine, antibiotics), End user– Forecast till 2032.

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Brucellosis Market, by Species

6.1 Introduction

6.2 Brucella suis

6.2.1 Market Estimates & Forecast, 2016 – 2023

6.3 Brucella abortus

6.3.1 Market Estimates & Forecast, 2016 – 2023

6.4 Brucella melitensis

6.4.1 Market Estimates & Forecast, 2016 – 2023

6.5 Brucella canis

6.5.1 Market Estimates & Forecast, 2016 – 2023

6.5 Others

Chapter 7. Global Brucellosis Market, by Diagnosis

7.1 Introduction

7.2 Serological tests

7.2.1 Market Estimates & Forecast, 2017 – 2023

7.2.2 Serum agglutination test

7.2.2.1 Market Estimates & Forecast, 2017 – 2023

7.2.3 Rose Bengal test

7.2.3.1 Market Estimates & Forecast, 2017 – 2023

7.2.4 Lateral flow assay

7.2.4.1 Market Estimates & Forecast, 2017 – 2023

7.2.5 Compliment fixation test

7.2.5.1 Market Estimates & Forecast, 2017 – 2023

7.2.6 Coombs test

7.2.6.1 Market Estimates & Forecast, 2017 – 2023

7.2.7 Enzyme linked immuno sorbent assay

7.2.7.1 Market Estimates & Forecast, 2017 – 2023

7.2.8 Immunocapture-agglutination test (brucellacapt)

7.2.8.1 Market Estimates & Forecast, 2017 – 2023

7.3 Molecular techniques

7.3.1 Market Estimates & Forecast, 2017 – 2023

7.3.2 Polymerase Chain Reaction (PCR)

7.3.2.1 Market Estimates & Forecast, 2017 – 2023

7.3.2.2 Standard PCR

7.3.2.2.1 Market Estimates & Forecast, 2017 – 2023

7.3.2.3 Real time PCR

7.3.2.3.1 Market Estimates & Forecast, 2017 – 2023

7.3.2.4 Nested PCR

7.3.2.4.1 Market Estimates & Forecast, 2017 – 2023

7.3.2.5 PCR based assays

7.3.2.5.1 Market Estimates & Forecast, 2017 – 2023

7.3.3 Loop- mediated isothermal amplification assay

7.3.3.1 Market Estimates & Forecast, 2017 – 2023

7.3.4 Multiple Locus VNTR Analysis (MLVA) typing

7.3.4.1 Market Estimates & Forecast, 2017 – 2023

7.4 Bone marrow biopsy

7.4.1 Market Estimates & Forecast, 2017 – 2023

7.5 X-rays

7.5.1 Market Estimates & Forecast, 2017 – 2023

7.6 Computerized tomography (CT)

7.6.1 Market Estimates & Forecast, 2017 – 2023

7.7 Magnetic resonance imaging (MRI),

7.7.1 Market Estimates & Forecast, 2017 – 2023

7.8 Cerebrospinal fluid culture

7.8.1 Market Estimates & Forecast, 2017 – 2023

7.9 Echocardiography

7.9.1 Market Estimates & Forecast, 2017 – 2023

7.10 Others

Chapter 8. Global Brucellosis Market, by Treatment

8.1 Introduction

8.2 Antibiotics

8.2.1 Market Estimates & Forecast, 2017 – 2023

8.3 Vaccines

8.3.1 Market Estimates & Forecast, 2017 – 2023

8.4 Others

Chapter 9. Global Brucellosis Market, by End User

9.1 Introduction

9.2 Hospitals & Diagnostic Centers

9.2.1 Market Estimates & Forecast, 2017 – 2023

9.3 Academic Institutes

9.3.1 Market Estimates & Forecast, 2017 – 2023

9.4 Pharmaceutical & Biotechnology Companies

9.4.1 Market Estimates & Forecast, 2017 – 2023

9.5 Others

9.5.1 Market Estimates & Forecast, 2017 – 2023
Chapter. 10 Global Brucellosis Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 U.S.

10.2.1.1 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 U.K

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Rest of the The Middle East & Africa

Chapter 11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

Chapter 12 Company Profiles

12.1 Hester Biosciences Limited

12.1.1 Company Overview

12.1.2 Treatment Overview

12.1.3 Financials

12.1.4 SWOT Analysis

12.2 ATA FEN Inc.

12.2.1 Company Overview

12.2.2 Treatment Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Biogénesis-Bagó S.A.

12.3.1 Company Overview

12.3.2 Treatment Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Biopharma

12.4.1 Company Overview

12.4.2 Treatment/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Biovet

12.5.1 Company Overview

12.5.2 Treatment Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.6 Calier & Biologicos Laverlam

12.6.1 Company Overview

12.6.2 Treatment Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.7 Merck Animal Health

12.7.1 Overview

12.7.2 Treatment Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Colorado Serum Company

12.8.1 Company Overview

12.8.2 Treatment/Business Segment Overview

12.8.3 Financial Overview

12.8.4 Key Development

12.8.5 SWOT Analysis

12.9 Indian Immunologicals Limited

12.9.1 Company Overview

12.9.2 Treatment Overview

12.9.3 Financial overview

12.9.4 Key Developments

12.10 Others

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of Pharmaceutical industry

Chapter 14 Appendix
LIST OF TABLES
Table 1 Brucellosis Industry Synopsis, 2017 – 2023

Table 2 Brucellosis Market Estimates and Forecast, 2017 – 2023, (USD Million)

Table 3 Brucellosis Market by Region, 2017 – 2023, (USD Million)

Table 4 Brucellosis Market by Species, 2017 – 2023, (USD Million)

Table 5 Brucellosis Market by Diagnosis, 2017 – 2023, (USD Million)

Table 6 Brucellosis Market by Treatment, 2017 – 2023, (USD Million)

Table 7 Brucellosis Market by End Users, 2017 – 2023, (USD Million)

Table 8 North America Brucellosis Market by Species, 2017 – 2023, (USD Million)

Table 9 North America Brucellosis Market by Diagnosis, 2017 – 2023, (USD Million)

Table 10 North America Brucellosis Market by Treatment, 2017 – 2023, (USD Million)

Table 11 North America Brucellosis Market by End User, 2017 – 2023, (USD Million)

Table 12 US Brucellosis Market by Species, 2017 – 2023, (USD Million)

Table 13 US Brucellosis Market by Diagnosis, 2017 – 2023, (USD Million)

Table 14 US Brucellosis Market by Treatment, 2017 – 2023, (USD Million)

Table 15 US Brucellosis Market by End User, 2017 – 2023, (USD Million)

Table 16 Canada Brucellosis Market by Species, 2017 – 2023, (USD Million)

Table 17 Canada Brucellosis Market by Diagnosis, 2017 – 2023, (USD Million)

Table 18 Canada Brucellosis Market by Treatment, 2017 – 2023, (USD Million)

Table 19 Canada Brucellosis Market by End User, 2017 – 2023, (USD Million)

Table 20 South America Brucellosis Market by Species, 2017 – 2023, (USD Million)

Table 21 South America Brucellosis Market by Diagnosis, 2017 – 2023, (USD Million)

Table 22 South America Brucellosis Market by Treatment, 2017 – 2023, (USD Million)

Table 23 South America Brucellosis Market by End User, 2017 – 2023, (USD Million)

Table 24 Europe Brucellosis Market by Species, 2017 – 2023, (USD Million)

Table 25 Europe Brucellosis Market by Diagnosis, 2017 – 2023, (USD Million)

Table 26 Europe Brucellosis Market by Treatment, 2017 – 2023, (USD Million)

Table 27 Europe Brucellosis Market by End User, 2017 – 2023, (USD Million)

Table 28 Western Europe Brucellosis Market by Species, 2017 – 2023, (USD Million)

Table 29 Western Europe Brucellosis Market by Diagnosis, 2017 – 2023, (USD Million)

Table 30 Western Europe Brucellosis Market by Treatment, 2017 – 2023, (USD Million)

Table 31 Western Europe Brucellosis Market by End User, 2017 – 2023, (USD Million)

Table 32 Eastern Europe Brucellosis Market by Species, 2017 – 2023, (USD Million)

Table 33 Eastern Europe Brucellosis Market by Diagnosis, 2017 – 2023, (USD Million)

Table 34 Eastern Europe Brucellosis Market by Treatment, 2017 – 2023, (USD Million)

Table 35 Eastern Europe Brucellosis Market by End User, 2017 – 2023, (USD Million)

Table 36 Asia Pacific Brucellosis Market by Species, 2017 – 2023, (USD Million)

Table 37 Asia Pacific Brucellosis Market by Diagnosis, 2017 – 2023, (USD Million)

Table 38 Asia Pacific Brucellosis Market by Treatment, 2017 – 2023, (USD Million)

Table 39 Asia Pacific Brucellosis Market by End User, 2017 – 2023, (USD Million)

Table 40 The Middle East & Africa Brucellosis Market by Species, 2017 – 2023, (USD Million)

Table 41 The Middle East & Africa Brucellosis Market by Diagnosis, 2017 – 2023, (USD Million)

Table 42 The Middle East & Africa Brucellosis Market by Treatment, 2017 – 2023, (USD Million)

Table 43 The Middle East & Africa Brucellosis Market by End User, 2017 – 2023, (USD Million)
LIST OF FIGURES
Figure 1 Research Process

Figure 2 Segmentation for Brucellosis Market

Figure 3 Segmentation Market Dynamics for Brucellosis Market

Figure 4 Global Brucellosis Market Share, by Species 2016

Figure 5 Global Brucellosis Market Share, by Diagnosis 2016

Figure 6 Global Brucellosis Market Share, by Treatment, 2016

Figure 8 Global Brucellosis Market Share, by Technology, 2016

Figure 9 Global Brucellosis Market Share, by End Users, 2016

Figure 10 Global Brucellosis Market Share, by Region, 2016

Figure 11 North America Brucellosis Market Share, by Country, 2016

Figure 12 Europe Brucellosis Market Share, by Country, 2016

Figure 13 Asia Pacific Brucellosis Market Share, by Country, 2016

Figure 14 The Middle East & Africa Brucellosis Market Share, by Country, 2016

Figure 15 Global Brucellosis Market: Company Share Analysis, 2016 (%)

Figure 16 Hester Biosciences Limited: Key Financials

Figure 17 Hester Biosciences Limited: Segmental Revenue

Figure 18 Hester Biosciences Limited: Geographical Revenue

Figure 19 ATA FEN Inc.: Key Financials

Figure 20 ATA FEN Inc.: Segmental Revenue

Figure 21 ATA FEN Inc.: Geographical Revenue

Figure 22 Biogénesis-Bagó S.A.: Key Financials

Figure 23 Biogénesis-Bagó S.A.: Segmental Revenue

Figure 24 Biogénesis-Bagó S.A.: Geographical Revenue

Figure 25 Biopharma: Key Financials

Figure 26 Biopharma: Segmental Revenue

Figure 27 Biopharma: Geographical Revenue

Figure 28 Biovet: Key Financials

Figure 29 Biovet: Segmental Revenue

Figure 30 Biovet: Geographical Revenue

Figure 32 Calier & Biologicos Laverlam: Key Financials

Figure 33 Calier & Biologicos Laverlam: Segmental Revenue

Figure 34 Calier & Biologicos Laverlam: Geographical Revenue

Figure 35 Merck Animal Health: Key Financials

Figure 36 Merck Animal Health: Segmental Revenue

Figure 37 Merck Animal Health: Geographical Revenue

Figure 38 Colorado Serum Company: Key Financials

Figure 39 Colorado Serum Company: Segmental Revenue

Figure 40 Colorado Serum Company: Geographical Revenue

Figure 41 Indian Immunologicals Limited: Key Financials

Figure 42 Indian Immunologicals Limited: Segmental Revenue

Figure 43 Indian Immunologicals Limited: Geographical Revenue